Skip to main navigation Skip to search Skip to main content

DNA methylation and hydroxymethylation in hematologic differentiation and transformation

  • Myunggon Ko*
  • , Jungeun An
  • , Anjana Rao
  • *Corresponding author for this work
  • Ulsan National Institute of Science and Technology
  • La Jolla Institute for Allergy and Immunology
  • University of California at San Diego
  • Sanford Consortium for Regenerative Medicine

Research output: Contribution to journalReview articlepeer-review

Abstract

Maintenance of the balance of DNA methylation and demethylation is fundamental for normal cellular development and function. Members of the Ten-Eleven-Translocation (TET) family proteins are Fe(II)-dependent and 2-oxoglutarate-dependent dioxygenases that catalyze sequential oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and subsequent oxidized derivatives in DNA. In addition to their roles as intermediates in DNA demethylation, these oxidized methylcytosines are novel epigenetic modifications of DNA. DNA methylation and hydroxymethylation profiles are markedly disrupted in a wide range of cancers but how these changes are related to the pathogenesis of cancers is still ambiguous. In this review, we discuss the current understanding of TET protein functions in normal and malignant hematopoietic development and the ongoing questions to be resolved.

Original languageEnglish
Pages (from-to)91-101
Number of pages11
JournalCurrent Opinion in Cell Biology
Volume37
DOIs
StatePublished - 2015.12.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'DNA methylation and hydroxymethylation in hematologic differentiation and transformation'. Together they form a unique fingerprint.

Cite this